欧诺宁通过PKM2脱乙化调节SIRT2介导的葡萄糖分解和LPS激活的微质中的炎症
Qunshan Chen1, Weixian Xu2, Xiaofang Tong3
1Pain Management Centre, Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, HangZhou, China.
Brain research
|June 8, 2025
概括
一种植物化合物欧诺宁通过抑制微质炎症和糖解来显示神经病痛的治疗潜力. 它通过调节SIRT2来抑制PKM2蛋白稳定性而起作用,提供了一个有前途的治疗选择.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 微质炎症和糖解是神经病痛治疗的关键点.
- 奥诺宁是一种植物性化合物,具有抗炎和抗瘤的特性.
研究的目的:
- 探索奥诺宁在治疗神经病痛方面的治疗潜力.
- 阐明欧诺宁对微质激活的作用机制.
主要方法:
- 用LPS刺激BV2微质细胞以模拟神经病痛状况.
- 在奥诺宁治疗后,使用qPCR阵列分析基因表达.
- 研究了欧诺宁,SIRT2和PKM2乙化在炎症和糖解中的作用.
主要成果:
- 在LPS治疗的BV2细胞中,欧诺宁 (40μM) 显著降低了炎症和糖解,与增加的SIRT2水平相关.
- 抑制SIRT2降低了欧诺宁的作用,并促进了PKM2的乙化,从而增强了糖解.
- 在K207部位,SIRT2去乙PKM2,降低PKM2蛋白的稳定性.
结论:
- 在神经病痛中,SIRT2介导的代谢重编程和炎症至关重要.
- 奥诺宁通过利用SIRT2通过脱乙化来降低PKM2蛋白稳定性,证明了其治疗潜力.
- 奥诺宁代表了神经病痛治疗的有希望的候选人.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


